FDA applicant
Hemocue, Inc.
FDA records 15 decisions for Hemocue, Inc. (Potomac, MD) from 1991 to 2020: 15 510(k) clearances. Most are in product codes GKR (System, Hemoglobin, Automated) and LFR (Glucose Dehydrogenase, Glucose). Its devices cite 5 predicates, 4 of them its own earlier devices. 10 recalls are linked to its devices.
FDA’s records also spell it “Hemocue AB”.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Hemocue, Inc.’s devices, and how often a recall has named them.
FDA decisions per year
1in 2020
2026 so far, outlined.
Recalls per year
2in 2025
Class I Class II/III not classified
Planning a device like Hemocue, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report